Implementación en la Farmacia Hospitalaria

Implementation of Pharmacogenetics: An Overview

Introduction to the MOOC

• Andrés Corno introduces himself as an expert in clinical pharmacogenetics with over 15 years of experience in genetic drugs.

• The objective of the MOOC is to provide insights into the realities and developments of pharmacogenetics implementation projects, particularly in America and Europe.

Key Projects in Pharmacogenetics

• Focus on two main projects: the European Prepare project and the American Ignite initiative, which serve as guides for implementing pharmacogenetic activities.

• Reference to a specific pharmacogenetics unit at Hospital de la Paz in Madrid, which has treated over 2,000 patients.

The Prepare Project

• The Prepare project involved seven countries and aimed to reduce adverse drug effects by analyzing pharmacogenetic variants among 8,000 patients over two and a half years.

• A significant challenge was the variability in health systems across different countries; electronic medical records were essential but varied greatly.

Safety Code Card Implementation

• Introduction of a safety code card featuring a QR code that contains patient data related to gene analysis for drug metabolism.

• This system allows healthcare providers to access tailored pharmacotherapeutic interventions based on individual genetic profiles, aiming for a reduction in adverse effects from 4% to 2.8%.

Insights from the Ignite Initiative

• The Ignite initiative is broader than just pharmacogenetics; it also encompasses genomics applications for various health conditions including monogenic diseases and diabetes.

• It aims to establish diverse application models linked with major hospitals and universities while focusing on practical implementations rather than solely preventive measures.

Ignite's Insights on Genotyping and Patient Care

Key Conclusions from Ignite

• The analysis focused on saliva samples, utilizing genotyping techniques aimed at enhancing patient care. The speaker emphasizes three main conclusions but opts not to read them verbatim.

• Since 2013, Ignite has highlighted the critical need for training and information dissemination among healthcare professionals, as many lack knowledge about these advanced tools and techniques.

• There is a pressing need to develop computational tools that can streamline clinical processes. These tools are essential for managing complex information and generating final reports efficiently.

• Current bottlenecks in healthcare arise from the complexity of information management. Without effective tools to systematize data application, implementation becomes challenging.

• The discussion touches on financial aspects of genetic analyses, suggesting a co-payment model similar to drug usage in oncology. This model could help manage costs associated with long-term and expensive treatments based on genotype efficacy.

Financial Considerations in Genetic Testing

• The speaker expresses a personal opinion advocating for co-payments in genetic testing outside of oncology, indicating that while some treatments are covered entirely by the system, others may require patient contributions based on their specific gene variations.